MedTrace Logo

A Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System

NCT05044793 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2025-01-22

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the long-term safety and effectiveness of the OMNI® Surgical System in subjects who were treated under protocol #06213

Conditions

  • Glaucoma, Open-Angle

Interventions

DEVICE

OMNI® Surgical System

The OMNI® Surgical System is indicated for canaloplasty (microcatheterization and transluminal viscodilation of Schlemm's canal) followed by trabeculotomy (cutting of trabecular meshwork) to reduce intraocular pressure in adult patients with primary open-angle glaucoma.

Sponsors & Collaborators

  • Sight Sciences, Inc.

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2023-08-21
Completion
2023-08-21
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05044793 on ClinicalTrials.gov